Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Scientific Reports|August 19, 2023
Numerical analysis for tangent-hyperbolic micropolar nanofluid flow over an extending layer through a permeable mediumGalal M Moatimid, Mona A A Mohamed, Ahmed A Gaber, et al.
Bioorganic Chemistry|July 10, 2018
Design, synthesis and anticancer evaluation of 1H-pyrazolo[3,4-d]pyrimidine derivatives as potent EGFR<sup>WT</sup> and EGFR<sup>T790M</sup> inhibitors and apoptosis inducersAhmed A Gaber, Ashraf H Bayoumi, Ahmed M El-Morsy, et al.
Seizure|February 28, 2012
Elevated serum Bcl-2 in children with temporal lobe epilepsyAyman Kilany, Ehab R Abdel Raouf, Ahmed A Gaber, et al.
Environmental Science and Pollution Research International|June 18, 2022
Silver nanoparticles induced hepatoxicity via the apoptotic/antiapoptotic pathway with activation of TGFβ-1 and α-SMA triggered liver fibrosis in Sprague Dawley ratsDoaa H Assar, Abd-Allah A Mokhbatly, Emad W Ghazy, et al.
Bioorganic Chemistry|February 22, 2024
Multi-target rational design and synthesis of novel diphenyl-tethered pyrazolopyrimidines targeting EGFR and topoisomerase II with potential DNA intercalation and apoptosis inductionAhmed A Gaber, Ayman Abo Elmaaty, Marwa Sharaky, et al.
Environmental Science and Pollution Research International|November 11, 2022
Silver nanoparticles induced testicular damage targeting NQO1 and APE1 dysregulation, apoptosis via Bax/Bcl-2 pathway, fibrosis via TGF-β/α-SMA upregulation in ratsDoaa H Assar, Abd-Allah A Mokhbatly, Mohamed F Abou ELazab, et al.
Pharmaceuticals (Basel, Switzerland)|June 26, 2026
Design, Synthesis, and Biological Evaluation of Tetrahydroindazole-Based Sulfonamides as Potential Multi-Target Anti-Inflammatory AgentsMohammed A I Elbastawesy, Ahmed H Abdelhafez, Abdullah Yahya Abdullah Alzahrani, et al.
Future Medicinal Chemistry|October 26, 2023
Design and synthesis of novel pyrazolopyrimidine candidates as promising EGFR-T790M inhibitors and apoptosis inducersAhmed A Gaber, Marwa Sharaky, Ayman Abo Elmaaty, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|August 24, 2022
Discovery of new 1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine derivatives as anticancer agents targeting EGFR<sup>WT</sup> and EGFR<sup>T790M</sup>Ahmed A Gaber, Mohamed Sobhy, Abdallah Turky, et al.
Archiv Der Pharmazie|September 1, 2021
Pharmacophore-linked pyrazolo[3,4-d]pyrimidines as EGFR-TK inhibitors: Synthesis, anticancer evaluation, pharmacokinetics, and in silico mechanistic studiesAhmed A Gaber, Ahmed M El-Morsy, Farag F Sherbiny, et al.
Pageof 2